TreeFrog Therapeutics
Phase 1TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.
Founded
2018
Focus
Cell TherapyRegenerative Medicine
About
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.
Funding History
3Total raised: $141.8M
Series B$75MBpifranceSep 15, 2023
Series A$64MBpifranceJun 15, 2021
Seed$2.8MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2018
LocationBordeaux, France
StagePhase 1
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile